Exporter

You can select particular sections to be included in the output file.
EN
FR

Liste modèle des médicaments essentiels

effacer Trouvé 55 recommandations pour 45 médicaments et 10 équivalents thérapeutiques
Les recommandations supprimées et les demandes rejetées sont affichées. Les cacher.
5.1. Antiseizure medicines
  1. Acetylsalicylic acid Informations générales
    Section
    Medicines for acute migraine attacks
    • Oral > Solid: 300 to 500 mg
    Indications
    Migraine
  2. Aciclovir Informations générales
    Section
    Medicines for viral central nervous system infections
    • Parenteral > General injections > IV: 250 mg in vial powder for solution for infusion (as sodium dihydrate); 25 mg per mL in vial solution for infusion (as sodium)
    • Oral > Liquid: 200 mg per 5 mL
    • Oral > Solid: 200 mg tablet
    • Parenteral > General injections > IV: 250 mg in vial powder for solution for infusion (as sodium diihydrate); 25 mg per mL in vial solution for infusion (as sodium)
    Indications
    Herpes simplex infections Zoster Varicella
  3. Amitriptyline Informations générales
    Section
    Medicines for migraine prophylaxis
    • Oral > Solid > tablet: 25 mg
    Indications
    Migraine
  4. Amoxicillin Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
    • Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
    • Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
    • Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
    Indications
    Second choix
    Bacterial meningitis
  5. Ampicillin Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
    Indications
    Second choix
    Bacterial meningitis
  6. Baclofen Informations générales
    Section
    Medicines for cerebral palsy
    • Oral > Liquid: 10 mg per 5 mL
    • Parenteral > Locoregional injections > Intrathecal: 500 µg per mL in ampoule
    • Oral > Solid > tablet: 10 mg
    Indications
    Spastic cerebral palsy
  7. Benzylpenicillin Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
    Indications
    Second choix
    Bacterial meningitis
  8. Biperiden Informations générales
    Section
    Medicines for parkinsonism
    • Parenteral > General injections > IV: 5 mg per mL in 1 mL ampoule (lactate)
    • Oral > Solid: 2 mg tablet (hydrochloride)
    Indications
    Parkinson disease
  9. Bisoprolol Informations générales
    Section
    Medicines for migraine prophylaxis
    • Oral > Solid: 1.25 mg; 5 mg
    Indications
    Migraine
  10. Bromocriptine Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid: 2.5 mg; 5 mg
    Indications
    Parkinson disease
  11. Cabergoline Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid > tablet: 0.5 mg
    Indications
    Parkinson disease
  12. Carbamazepine Informations générales
    Section
    Antiseizure medicines
    • Oral > Liquid: 100 mg per 5 mL
    • Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored)
    Indications
    Epilepsy or seizures
  13. Cefotaxime Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    Indications
    Premier choix
    Bacterial meningitis
  14. Ceftriaxone Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    Indications
    Premier choix
    Bacterial meningitis
  15. Chloramphenicol Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate)
    • Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection
    Indications
    Second choix
    Bacterial meningitis
  16. Cladribine Informations générales
    Section
    Medicines for multiple sclerosis
    • Oral > Solid > tablet: 10 mg
    Indications
    Multiple sclerosis
  17. Clonazepam Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid: 500 µg
    Indications
    Generalised myoclonic seizure
  18. Diazepam Informations générales
    Section
    Antiseizure medicines
    • Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system
    • Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube
    Indications
    Therapeutic equivalent to lorazepam pour Status epilepticus Status epilepticus
  19. Dihydroergocryptine mesylate Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid:
    Indications
    Parkinson disease
  20. Eletriptan Informations générales
    Section
    Medicines for acute migraine attacks
    • Oral > Solid > tablet: 40 mg
    Indications
    Therapeutic equivalent to sumatriptan pour Migraine
  21. Eptinezumab Informations générales
    Section
    Medicines for migraine prophylaxis
    Indications
    Therapeutic equivalent to fremanezumab pour Chronic migraine
  22. Erenumab Informations générales
    Section
    Medicines for migraine prophylaxis
    Indications
    Therapeutic equivalent to fremanezumab pour Chronic migraine
  23. Ethosuximide Informations générales
    Section
    Antiseizure medicines
    • Oral > Liquid: 250 mg per 5 mL
    • Oral > Solid: 250 mg
    Indications
    Absence seizures, typical
  24. Fremanezumab Informations générales
    Section
    Medicines for migraine prophylaxis
    • Parenteral > General injections > SC: 225 mg per 1.5 mL in pre-filled syringe
    Indications
    Chronic migraine
  25. Galcanezumab Informations générales
    Section
    Medicines for migraine prophylaxis
    Indications
    Therapeutic equivalent to fremanezumab pour Chronic migraine
  26. Gentamicin Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Parenteral > General injections > unspecified: 10 mg per mL in 2 mL vial (as sulfate); 40 mg per mL in 2 mL vial (as sulfate)
    Indications
    Premier choix
    Neonatal meningitis
  27. Glatiramer acetate Informations générales
    Section
    Medicines for multiple sclerosis
    • Parenteral > General injections > SC: 20 mg per mL in pre-filled syringe; 40 mg per mL in pre-filled syringe
    • Parenteral > General injections > SC: 20 mg per mL; 40 mg per mL
    Indications
    Multiple sclerosis Relapsing-remitting multiple sclerosis
  28. Ibuprofen Informations générales
    Section
    Medicines for acute migraine attacks
    • Oral > Liquid: 100 mg per 5 mL; 200 mg per 5 mL
    • Oral > Solid > tablet: 200 mg; 400 mg
    Indications
    Migraine
  29. Lamotrigine Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet; 200 mg tablet; 2 mg tablet (chewable, dispersible); 5 mg tablet (chewable, dispersible); 25 mg tablet (chewable, dispersible); 50 mg tablet (chewable, dispersible); 100 mg tablet (chewable, dispersible); 200 mg tablet (chewable, dispersible)
    Indications
    Epilepsy or seizures
  30. Levetiracetam Informations générales
    Section
    Antiseizure medicines
    • Oral > Liquid: 100 mg per mL
    • Oral > Solid > tablet: 250 mg; 500 mg; 750 mg; 1000 mg
    • Parenteral > General injections > IV: 100 mg per mL in 5 mL ampoule or vial; 5 mg per mL in 100 mL bag; 10 mg per mL in 100 mL bag; 15 mg per mL in 100 mL bag
    Indications
    Epilepsy or seizures Status epilepticus
  31. Levodopa Informations générales
    Section
    Medicines for parkinsonism
    • Oral > Solid: 250 mg
    Indications
    Parkinson disease
  32. Levodopa + benserazide Informations générales
    Section
    Medicines for parkinsonism
    Indications
    Therapeutic equivalent to levodopa + carbidopa pour Parkinson disease
  33. Levodopa + carbidopa Informations générales
    Section
    Medicines for parkinsonism
    • Oral > Solid: 100 mg + 10 mg tablet; 250 mg + 25 mg tablet; 100 mg + 25 mg tablet
    Indications
    Parkinson disease
  34. Lorazepam Informations générales
    Section
    Antiseizure medicines
    • Parenteral > General injections > IV: 2 mg per mL in 1 mL ampoule; 4 mg per mL in 1 mL ampoule
    Indications
    Status epilepticus
  35. Magnesium sulfate Informations générales
    Section
    Antiseizure medicines
    • Parenteral > General injections > IV: 500 mg per mL in 2 mL ampoule (equivalent to 1 g in 2 mL; 50% weight/volume)
    • Parenteral > General injections > IM: 500 mg per mL in 10 mL ampoule (equivalent to 5 g in 10 mL; 50% weight/volume)
    Indications
    Severe pre-eclampsia Eclampsia
  36. Meropenem Informations générales
    Section
    Medicines for bacterial central nervous system infections
    • Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection
    Indications
    Second choix
    Neonatal meningitis
  37. Midazolam Informations générales
    Section
    Antiseizure medicines
    • Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial (for buccal administration); 5 mg per mL in 1 mL vial (for buccal administration); 5 mg per mL in 3 mL vial (for buccal administration)
    • Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration)
    Indications
    Status epilepticus Therapeutic equivalent to lorazepam pour Status epilepticus
  38. Naproxen Informations générales
    Section
    Medicines for acute migraine attacks
    Indications
    Therapeutic equivalent to ibuprofen pour Migraine
  39. Ocrelizumab Informations générales
    Section
    Medicines for multiple sclerosis
    • Parenteral > General injections > IV: 30 mg per mL in 10 mL vial
    • Parenteral > General injections > IV: 30 mg per mL in 10 vial concentrate for solution
    Indications
    Relapsing-remitting multiple sclerosis Multiple sclerosis
  40. Paracetamol (acetaminophen) Informations générales
    Section
    Medicines for acute migraine attacks
    • Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL
    • Local > Rectal > Suppository: 250 mg
    • Oral > Solid > dispersible tablet: 100 mg; 250 mg
    • Oral > Solid > tablet: 250 mg; 325 mg; 500 mg
    Indications
    Migraine
  41. Phenobarbital Informations générales
    Section
    Antiseizure medicines
    • Parenteral > General injections > IV: 200 mg per mL (phenobarbital sodium); 30 mg per mL (phenobarbital sodium); 60 mg per mL (phenobarbital sodium)
    • Oral > Liquid: 15 mg per 5 mL
    • Oral > Solid > tablet: 15 mg; 30 mg; 60 mg; 100 mg
    Indications
    Status epilepticus Epilepsy or seizures
  42. Phenytoin Informations générales
    Section
    Antiseizure medicines
    • Oral > Liquid: 30 mg per 5 mL (phenytoin)
    • Parenteral > General injections > unspecified: 50 mg per mL in vial (phenytoin sodium)
    • Oral > Solid > tablet: 50 mg (phenytoin) (chewable)
    • Oral > Solid > dosage form: 25 mg (phenytoin sodium); 50 mg (phenytoin sodium); 100 mg (phenytoin sodium)
    Indications
    Epilepsy or seizures
  43. Pramipexole Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid: 125 µg immediate-release; 250 mg immediate-release; 500 µg immediate-release; 750 µg immediate-release; 1 mg immediate-release; 1.5 mg immediate-release; 375 µg extended-release; 750 µg extended-release; 1.5 mg extended-release; 2.25 mg extended-release; 3 mg extended-release; 3.75 mg extended-release; 4.5 extended-release
    Indications
    Parkinson disease
  44. Prednisolone Informations générales
    Section
    Medicines for cluster headache
    • Oral > Solid > tablet: 25 mg; 5 mg
    Indications
    Trigeminal autonomic cephalalgias
    Section
    Antiseizure medicines
    • Oral > Liquid: 1 mg per mL
    • Oral > Solid > tablet: 1 mg; 5 mg; 10 mg
    Indications
    Infantile spasms
  45. Propranolol Informations générales
    Section
    Medicines for migraine prophylaxis
    • Oral > Solid > tablet: 40 mg (hydrochloride); 10 mg (hydrochloride)
    Indications
    Migraine
  46. Rituximab Informations générales
    Section
    Medicines for multiple sclerosis
    • Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial
    Indications
    Multiple sclerosis
  47. Ropinirole Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid: 0.25 mg immediate-release; 0.5 mg immediate-release; 1 mg immediate-release; 2 immediate-release; 3 mg immediate-release; 4 mg immediate-release; 5 mg immediate-release; 2 mg extended-release; 4 mg extended-release; 6 mg extended-release; 8 mg extended-release; 12 mg extended-release
    Indications
    Parkinson disease
  48. Sumatriptan Informations générales
    Section
    Medicines for acute migraine attacks
    • Oral > Solid > tablet: 50 mg
    Indications
    Migraine
    Section
    Medicines for cluster headache
    • Parenteral > General injections > SC: 6 mg per 0.5 mL in pre-filled pen; 6 mg per 0.5 mL in pre-filled syringe
    Indications
    Trigeminal autonomic cephalalgias
  49. Trihexyphenidyl Informations générales
    Section
    Antiseizure medicines
    • Oral > Solid: 2 mg (hydrochloride); 5 mg (hydrochloride)
    Indications
    Parkinson disease
    Section
    Medicines for parkinsonism
    Indications
    Therapeutic equivalent to biperiden pour Parkinson disease
  50. Valaciclovir Informations générales
    Section
    Medicines for viral central nervous system infections
    Indications
    Therapeutic equivalent to aciclovir pour Herpes simplex infections Therapeutic equivalent to aciclovir pour Zoster Therapeutic equivalent to aciclovir pour Varicella
  51. Valproic acid (sodium valproate) Informations générales
    Section
    Antiseizure medicines
    • Oral > Liquid: 200 mg per 5 mL
    • Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated); 100 mg tablet (crushable)
    • Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule; 100 mg per mL in 3 mL ampoule
    Indications
    Epilepsy or seizures Status epilepticus
  52. Verapamil Informations générales
    Section
    Medicines for cluster headache
    • Oral > Solid > tablet: 120 mg (hydrochloride) (immediate-release); 40 mg (hydrochloride) (immediate-release); 80 mg (hydrochloride) (immediate-release); 120 mg (hydrochloride) (extended-release); 180 mg (hydrochloride) (extended-release); 240 mg (hydrochloride) (extended-release)
    Indications
    Trigeminal autonomic cephalalgias